Opus Genetics, Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Opus Genetics, Inc.
Quantité totale PI 43
Rang # Quantité totale PI 33 276
Note d'activité PI 2,6/5.0    43
Rang # Activité PI 17 113
Symbole boursier IRD (nasdaq)
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

31 8
1 0
3 0
0
 
Dernier brevet 2025 - Compositions comprising an apx33...
Premier brevet 2014 - Aqueous ophthalmic solutions of ...
Dernière marque 2022 - RYZUMVI
Première marque 2003 - NYXOL

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Aqueous ophthalmic solutions of phentolamine and medical uses thereof. The invention provides aq...
Invention Compositions comprising an apx3330 hemicalcium salt monohydrate and therapeutic uses thereof. Thi...
Invention Methods and compositions for treatment of mydriasis. The invention provides methods, composition...
2024 Invention Phentolamine mesylate and therapeutic uses thereof. This invention provides phentolamine mesylate...
Invention Highly pure phentolamine mesylate and methods for making same. This invention provides methods f...
Invention Salts and esters of apx3330 and therapeutic uses thereof. This invention relates to Compound 1 (A...
Invention Phentolamine mesylate and therapeutic uses thereof. This invention provides phentolamine mesylat...
Invention Gene therapy for ocular disease. Methods and compositions for gene therapy of retinal degeneratio...
2023 Invention Aqueous ophthalmic solutions of phentolamine and medical uses thereof. The invention provides aqu...
P/S Pharmaceutical products for ophthalmological use; Pharmaceutical preparations for the prevention ...
Invention Salts and esters of apx3330 and therapeutic uses thereof. This invention relates to Compound 1 (...
Invention Methods and compositions for daily ophthalmic administration of phentolamine to improve visual pe...
2022 Invention Highly pure phentolamine mesylate. This invention provides methods for synthesizing phentolamine ...
P/S Research and development in the pharmaceutical field; consulting services in the field of pharmac...
P/S PHARMACEUTICAL PRODUCTS FOR OPHTHALMOLOGICAL USE; PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION ...
Invention Methods and compositions for treatment of mydriasis. The invention provides methods, compositions...
Invention Highly pure phentolamine mesylate and methods for making same. This invention provides methods fo...
Invention Methods and compositions for treatment of diabetic retinopathy and related conditions. The inven...
Invention Methods and compositions for treating mydriasis, glaucoma, and other ocularconditions. The inven...
Invention Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders. The ...
P/S pharmaceutical and biologic preparations for the diagnosis and treatment of retinal and ocular di...
P/S research and development services in the field of retinal and ocular diseases; research and devel...
2021 Invention Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders. The...
2019 Invention Methods and compositions for treatment of glaucoma and related conditions. Methods, compositions ...
2003 P/S eye solutions and formulations for managing pupil size